INVESTIGADORES
NANNINI Esteban
artículos
ESTEBAN C. NANNINI; MATIAS LAHITTE; PABLO SCAPELLATO; CORINA NEMIROVSKY; MARCELO ZYLBERMAN; ANALIA MYKIETIUK; ADRIANA S. LIMANSKY; PATRICIA MARCHIARO; MARIANGEL RINAUDO
Diversity of hypervirulent Klebsiella pneumoniae clones causing cryptogenic liver abscesses and metastatic complications in Argentina
REVISTA ARGENTINA DE MICROBIOLOGÃA; Lugar: Buenos Aires; Año: 2025
JUAN P. BALBUENA; EZEQUIEL CORDOVA; ANALIA MYKIETIUK; PABLO SCAPELATTO; ESTEBAN NANNINI; MARTIN E. STRYJEWSKI
Carbapenem-resistant Gram-negative bacilli bacteremia in Argentina (EMBARCAR): findings from a prospective, multicenter cohort study
CLINICAL INFECTIOUS DISEASES; Lugar: Chicago; Año: 2025
ERIC E. CROCCI; DELFINA SCHREINER; EMILIA A. GARCIA; ESTEBAN C. NANNINI; MANUELA COBOS; MARÍA FERNANDA ALZOGARAY; ELSA BAUMEISTER; ANALÍA MYKIETIUK
Characteristics of endemic human coronavirus infections during times of COVID-19 pandemic
MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2024 vol. 84 p. 102 - 107
MANUELA COBOS; ESTEBAN C. NANNINI; JUAN P. BALBUENA; ERIC E. CROCCI; DELFINA SCHREINER; EMILIA A. GARCIA; SEBASTIAN CHAPARTEGUI; PAULA DOUBIK; ELSA BAUMEISTER; ANALIA MYKIETIUK
IMPACTO DE LA MOVILIDAD POBLACIONAL EN EL COMPORTAMIENTO DE VIRUS RESPIRATORIOS DURANTE LA PANDEMIA COVID-19
MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2023 vol. 83 p. 719 - 726
PERICHON, ARMANDO M.; ACOSTA, ANDREA; DI TULIO, LILIANA; MUNUCE, MARIA JOSÉ; PEZZOTTO, STELLA; BOTTASSO, OSCAR; NANNINI, ESTEBAN C.
Factors associated with mortality among hospitalized patients with COVID-19 disease treated with convalescent plasma
mBio; Lugar: Washington; Año: 2023
NANNINI, ESTEBAN
El significado de troponina en pacientes con COVID-19 severo
Revista de la Federacion Argentina de Cardiologia; Lugar: CABA; Año: 2022 vol. 51 p. 1 - 2
MORA OBED; INES TORESANI; ANALÍA MYKIETIUK; ESTEBAN C. NANNINI
Ceftaroline as salvage therapy for methicillin susceptible Staphylococcus aureus complicated bacteremia
MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2022 vol. 82 p. 794 - 797
FARIZANO SALAZAR, DIEGO H.; ACHINELLI, FERNANDO; COLONNA, MARIANA; PÉREZ, LUCÍA; GIMÉNEZ, ANALÍA A; OJEDA, MARIA ALEJANDRA; MIRANDA PUENTE, SUSANA N.; SÁNCHEZ NEGRETTE, LÍA; CAÑETE, FLORENCIA; MARTELOTTE IBARRA, ORNELA I.; SANGUINETI, SANTIAGO; SPATZ, LINUS; GOLDBAUM, FERNANDO A.; MASSA, CAROLINA; RIVAS, MARTA; PICHEL, MARIANA; HIRIART, YANINA; ZYLBERMAN, VANESA; GALLEGO, SANDRA; KONIGHEIM, BRENDA; FERNÁNDEZ, FRANCISCO; DEPRATI, MATÍAS; ROUBICEK, IAN; GIUNTA, DIEGO H.; NANNINI, ESTEBAN; LOPARDO, GUSTAVO; BELLOSO, WALDO H.
Safety and effectiveness of RBD-specific polyclonal equine F(ab´)2 fragments for the treatment of hospitalized patients with severe Covid-19 disease: A retrospective cohort study
PLOS ONE; Año: 2022 vol. 17
LOPARDO, GUSTAVO; BELLOSO, WALDO H.; NANNINI, ESTEBAN; COLONNA, MARIANA; SANGUINETTI, SANTIAGO; SUED, OMAR; CAHN, PEDRO; SPATZ, LINUS; GOLDBAUM, FERNANDO
RBD-specific polyclonal F(ab)2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial
EClinicalMedicine; Año: 2021 vol. 34
RINCON, S; CARVAJAL, L; GOMEZ-VILLEGAS, S; RIOS, RAFAEL; NANNINI, ESTEBAN; VANCE G. FOWLER, JR; MURRAY, BARBARA E.; PALLSKILL, T; ARIAS, CESAR A; REYES, JINNETHE
A Test for the Rapid Detection of the Cefazolin Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus
JOURNAL OF CLINICAL MICROBIOLOGY; Lugar: Washington; Año: 2021 vol. 59
SIMONOVICH, VENTURA A.; BURGOS PRATX, LEANDRO D.; SCIBONA, PAULA; NANNINI, ESTEBAN C.; LANE, H. CLIFFORD; BELLOSO, WALDO H.
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
NEW ENGLAND JOURNAL OF MEDICINE; Año: 2020
CORINA NEMIROVSKY; LOPEZ FURST, MARIA JOSE; PRYLUKA, DANIEL; NANNINI, ESTEBAN ; DE VEDIA, LAUTARO
CONSENSO ARGENTINO INTERSOCIEDADES DE INFECCIÓN URINARIA 2018-2019 - PARTE I
MEDICINA (BUENOS AIRES); Lugar: Buenos Aires; Año: 2020 vol. 80 p. 229 - 240
MILLER, WILLIAM R; SEAS, CARLOS; CARVAJAL, LINA P; DIAZ, LORENA; ECHEVERRI, AURA M; FERRO, CAROLINA; RIOS, RAFAEL; PORRAS, PAOLA; LUNA, CARLOS; GOTUZZO, EDUARDO; MUNITA, JOSE M; NANNINI, ESTEBAN; CARCAMO, CESAR; REYES, JINNETHE; ARIAS, CESAR A
The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia
Open Forum Infectious Diseases; Lugar: Cary, NC; Año: 2018 vol. 5
SINGH, KAVINDRA V.; TRAN, TRUC T.; NANNINI, ESTEBAN C.; TAM, VINCENT H.; ARIAS, CESAR A.; MURRAY, BARBARA E.
Efficacy of ceftaroline against methicillin-susceptible Staphylococcus aureus exhibiting the cefazolin high-inoculum effect in a rat model of endocarditis
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; Año: 2017 vol. 61
ORTIZ-COVARRUBIAS A; FANG E; PROKOCIMER PG; FLANAGAN SD; ZHU, X; CABRE-MARQUEZ JF; TANAKA T; PASSAREL, J; FRIEDLER-KELLY J; NANNINI EC
Efficacy, safety, tolerability and population pharmacokinetics of tedizolid, a novel antibiotic, in Latino patients with acute bacterial skin and skin structure infections
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES; Lugar: Bahia; Año: 2016 vol. 20 p. 184 - 192
ESTEBAN C. NANNINI; ADRIANA PONESSA; ROSA MURATORI; PATRICIA MARCHIARO; VIVIANA BALLERINI; LUIS FLYNN; ADRIANA S. LIMANSKY
Polyclonal outbreak of bacteremia caused by Burkholderia cepacia complex and the presumptive role of ultrasound gel
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES; Lugar: Bahia; Año: 2015 vol. 19 p. 543 - 545
ESTEBAN C. NANNINI; KAVINDRA V. SINGH; CESAR A. ARIAS; BARBARA E. MURRAY
In Vivo Effects of Cefazolin, Daptomycin, and Nafcillin in Experimental Endocarditis with a Methicillin-Susceptible Staphylococcus aureus Strain Showing an Inoculum Effect against Cefazolin
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; Lugar: Washington; Año: 2013 vol. 57 p. 4276 - 4281
RINCON, S; REYES, J; CARVAJAL, L; ROJAS, N; BARBARA E. MURRAY; ESTEBAN C. NANNINI; CESAR A. ARIAS
Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY; Lugar: Oxford; Año: 2013
ESTEBAN C. NANNINI; CESAR A. ARIAS
Occult Staphylococcus aureus bacteremia: other points to consider.
CLINICAL INFECTIOUS DISEASES; Lugar: Chicago; Año: 2013
ESTEBAN C. NANNINI; G. RALPH COREY,; MARTIN E. STRYJEWSKI
Telavancin for the treatment of hospital-acquired pneumonia: findings from the ATTAIN studies.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY; Año: 2012
ETHAN RUBINSTEIN; TAHANIYAT LALANI; G. RALPH COREY,; ZEINA A. KANAFANI; ESTEBAN C. NANNINI; MARCELO G. ROCHA,; GALIA RAHAV,; MICHAEL S. NIEDERMAN,; MARIN H. KOLLEF,; ANDREW F. SHORR,; PATRICK C. LEE; ANTONI TORRES,; DAVID FRIEDLAND,; MARTIN E. STRYJEWSKI
Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens.
CLINICAL INFECTIOUS DISEASES; Lugar: Chicago; Año: 2011
NANNINI EC; STRYJEWSKI ME; SINGH KV; RUDE TH
Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureus.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; Lugar: Washington; Año: 2010 vol. 54 p. 2206 - 2208
ESTEBAN C. NANNINI; BARBARA E. MURRAY; CESAR A. ARIAS
Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.
CURRENT OPINION IN PHARMACOLOGY; Lugar: Amsterdam; Año: 2010 vol. 10 p. 516 - 521
ESTEBAN C. NANNINI; MARTIN E. STRYJEWSKI; RALPH G. COREY
Ceftaroline for complicated skin and skin-structure infections.
EXPERT OPINION ON PHARMACOTHERAPY; Lugar: London; Año: 2010 vol. 11 p. 1197 - 1206
ESTEBAN C. NANNINI; MARTIN E. STRYJEWSKI
Pharmacotherapy Update: Daptomycin in the Management of Complicated Skin and Soft-tissue Infections.
Clinical Medicine Insights: Therapeutics; Lugar: Auckland; Año: 2010 vol. 10 p. 453 - 460
ESTEBAN C. NANNINI; MARTIN E. STRYJEWSKI; RALPH G. COREY
Telavancin's interactions with the bacterial cell membrane.
FUTURE MICROBIOLOGY; Lugar: Londres; Año: 2010
CROFOOT G; BARNETT BJ; NANNINI EC; SALVATO PD
HIV-treating physicians in Houston express their professional opinions on the public health implications of antiretroviral therapy.
Research Initiative Treatment Action; Lugar: Houston; Año: 2010
ESTEBAN C. NANNINI; MARTIN E. STRYJEWSKI; VANCE G. FOWLER, JR; BARBARA E. MURRAY
Inoculum Effect with Cefazolin among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus: Frequency and Possible Cause of Cefazolin Treatment Failure
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; Lugar: Washington; Año: 2009 vol. 53 p. 3437 - 3441
ESTEBAN C. NANNINI; MARTIN E. STRYJEWSKI
Review Article: A new lipoglycopeptide: telavancin.
EXPERT OPINION ON PHARMACOTHERAPY; Lugar: London; Año: 2008 vol. 9 p. 2197 - 2207
ESTEBAN C. NANNINI
Vancomycin-resistant enterococci-related mortality: focus on lack of appropriate therapy
CLINICAL INFECTIOUS DISEASES; Lugar: Chicago; Año: 2006
ESTEBAN C. NANNINI; FANG TENG; KAVINDRA V. SINGH; BARBARA E. MURRAY
Decreased Virulence of a gls24 Mutant of Enterococcus faecalis OG1RF in an Experimental Endocarditis Model.
INFECTION AND IMMUNITY; Lugar: Washington; Año: 2005 vol. 73 p. 7772 - 7774
FANG TENG; ESTEBAN C. NANNINI; BARBARA E. MURRAY
Importance of gls24 in Virulence and Stress Response of Enterococcus faecalis and Use of the Gls24 Protein as a Possible Immunotherapy Target.
JOURNAL OF INFECTIOUS DISEASES; Lugar: Chicago; Año: 2005
K. V. SINGH; S. R. NALLAPAREDDY; NANNINI EC; BARBARA E. MURRAY
Fsr Independent Production of Protease(s) May Explain the Lack of Attenuation of an Enterococcus faecalis fsr Mutant Versus a gelE-sprE Mutant in Induction of Endocarditis
INFECTION AND IMMUNITY; Lugar: Washington; Año: 2005
CASELLA JM; NANNINI EC; RADICE M; COCCONI E; LOVESIO C; FAY F
Estudio de un brote debido a aislados de Klebsiella pneumoniae productores de espectro extendido en un centro asistencial de Rosario-Argentina.
Revista Panamericana de Infectologia; Año: 2005
ARDUINO RC; NANNINI EC; RODRIGUEZ-BARRADAS M; SCHRADER S; LOSSO M; RUXRUNGTHAM K; ALLENDE MC; EMERY S; FOSDICK L; NEATON J; TAVEL JA; DAVEY RT; LANE HC
CD4 Cell Response to Three Doses of Subcutaneous Interleukin-2: Meta-analysis of Three Vanguard Studies
CLINICAL INFECTIOUS DISEASES; Lugar: Chicago; Año: 2004
ESTEBAN C. NANNINI; SURESH R. PAI; V. SINGH; BARBARA E. MURRAY
Activity of Tigecycline (GAR-936), a Novel Glycylcycline, against Enterococci in the Mouse Peritonitis Model
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY; Lugar: Washington; Año: 2003 vol. 47 p. 529 - 532
ESTEBAN C. NANNINI; KAVINDRA V. SINGH; BARBARA E. MURRAY
Relapse of type A β-lactamase producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: Revisiting the issue
CLINICAL INFECTIOUS DISEASES; Lugar: Chicago; Año: 2003 vol. 37 p. 1194 - 1198
ESTEBAN C. NANNINI; NIKI I. PAPHITOU; LUIS OSTROSKY-ZEICHNER
Peritonitis due to Aspergillus and zygomycetes in patients undergoing peritoneal dialysis: report of 2 cases and review of the literature
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASES; Lugar: Amsterdam; Año: 2003 vol. 46 p. 49 - 54
ESTEBAN C. NANNINI; PABLO C. OKHUYSEN
HIV-1 and the Gut in the Era of Highly Active Antiretroviral Therapy
Cur Gastroent Rep; Año: 2002 vol. 5 p. 392 - 398
ESTEBAN C. NANNINI; MICHAEL KEATING; DIMITRIOS KONTOYIANNIS
Successful Treatment of Refractory Disseminated Mycobacterium avium Complex Infection with the Addition of Linezolid and Mefloquine
THE JOURNAL OF INFECTION.; Lugar: Londres; Año: 2002 vol. 44 p. 201 - 203
ESTEBAN C. NANNINI; WILLIAM O´BRIEN; ROBERTO ARDUINO
Genotypic HIV-1 Drug Resistance Testing in Antiretroviral-Naïve Subjects in Houston, Texas.
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (1999); Lugar: Philadelphia; Año: 2002 vol. 29 p. 317 - 319
ESTEBAN C. NANNINI
Interleukin-2 in Clinical Trials: Other Factors to Be Considered
JOURNAL OF INFECTIOUS DISEASES; Lugar: Chicago; Año: 2001 vol. 183 p. 679 - 680
OKHUYSEN, P; ROBINSON, P; NGUYEN, MT; NANNINI EC; LEWIS, D; CHAPPELL, C; WHITE, A
Jejunal cytokine response in AIDS patients with chronic cryptosporidiosis and during immune reconstitution.
AIDS - AN INTERNATIONAL MONTHLY JOURNAL; Lugar: Philadelphia; Año: 2001
